Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEOPOLD Kids: Kovaltry in Children with Severe Hemophilia A
NCT01311648Phase 3Completed
- Sponsor
- Bayer
- Start
- Jun 2011
- Primary completion
- Sep 2019
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of damoctocog alfa pegol in hemophilia A, sponsored by Bayer. Started Jun 2011; status: completed.
02
Drugs
damoctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01311648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01311648.